Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1987-6-9
|
| pubmed:abstractText |
Twenty-one previously untreated patients with extensive small cell lung cancer were treated with etoposide, 400 mg/m2/day for 3 consecutive days. Myelosuppression was severe, with a treatment-related death rate of 28%. Five partial responses were achieved. High-dose etoposide as given in this study produced unacceptable toxicity and no complete responses.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0361-5960
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
71
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
533-4
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:3032434-Aged,
pubmed-meshheading:3032434-Carcinoma, Small Cell,
pubmed-meshheading:3032434-Etoposide,
pubmed-meshheading:3032434-Female,
pubmed-meshheading:3032434-Humans,
pubmed-meshheading:3032434-Lung Neoplasms,
pubmed-meshheading:3032434-Male,
pubmed-meshheading:3032434-Middle Aged
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|